These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 6145076)
1. Resolution in the receptor binding of putative mu and kappa opiates. Medzihradsky F; Dahlstrom PJ; Woods JH; Fischel SV; Mitsos SE Life Sci; 1984 May; 34(22):2129-38. PubMed ID: 6145076 [TBL] [Abstract][Full Text] [Related]
2. Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis. Fischel SV; Medzihradsky F Neuropharmacology; 1986 Apr; 25(4):351-9. PubMed ID: 3012397 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of opioid receptor binding in brain slices. Barchfeld-Rothschild CC; Medzihradsky F J Neurosci Res; 1987; 18(2):358-65. PubMed ID: 2891857 [TBL] [Abstract][Full Text] [Related]
4. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists). Chang KJ; Hazum E; Cuatrecasas P Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028 [TBL] [Abstract][Full Text] [Related]
5. Binding characteristics of kappa opioids in rat brain. A comparison of in vitro binding paradigms. Weyhenmeyer JA; Mack KJ Neuropharmacology; 1985 Feb; 24(2):111-5. PubMed ID: 2986030 [TBL] [Abstract][Full Text] [Related]
6. Differences of binding characteristics of non-selective opiates towards mu and delta receptor types. Delay-Goyet P; Roques BP; Zajac JM Life Sci; 1987 Aug; 41(6):723-31. PubMed ID: 3039270 [TBL] [Abstract][Full Text] [Related]
7. Opioid receptors of bovine posterior pituitary neurosecretosomes are exclusively kappa. Pesce GO; Lang MA; Cruciani RA; Russell JT; Gainer H; Rodbard D NIDA Res Monogr; 1986; 75():77-80. PubMed ID: 2893283 [TBL] [Abstract][Full Text] [Related]
8. Kappa binding sites in guinea-pig brain membranes: evidence for a dynorphin-resistant subtype. Morre M; Bachy A; Gout B; Boigegrain R; Arnone M; Roncucci R Life Sci; 1983; 33 Suppl 1():179-82. PubMed ID: 6141484 [TBL] [Abstract][Full Text] [Related]
9. Binding characteristics of mu and kappa agonists in rat brain subcellular fractions. Monferini E; Adler MW; Simon EJ Life Sci; 1982 Sep 20-27; 31(12-13):1295-8. PubMed ID: 6128655 [TBL] [Abstract][Full Text] [Related]
10. [3H]Mr 2034 labels a high affinity opioid kappa-receptor not accessible to naloxazone. Ensinger HA Eur J Pharmacol; 1983 Apr; 89(1-2):143-7. PubMed ID: 6305681 [TBL] [Abstract][Full Text] [Related]
12. Distinct high-affinity binding sites for benzomorphan drugs and enkephalin in a neuroblastoma--brain hybrid cell line. McLawhon RW; West RE; Miller RJ; Dawson G Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4309-13. PubMed ID: 6117074 [TBL] [Abstract][Full Text] [Related]
13. Kappa opiate binding sites in human placenta. Porthé G; Valette A; Cros J Biochem Biophys Res Commun; 1981 Jul; 101(1):1-6. PubMed ID: 6116490 [No Abstract] [Full Text] [Related]
14. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe. Stojilković SS; Dufau ML; Catt KJ Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471 [TBL] [Abstract][Full Text] [Related]
15. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes. Werling LL; Brown SR; Puttfarcken P; Cox BM Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504 [TBL] [Abstract][Full Text] [Related]
16. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. De Souza EB; Schmidt WK; Kuhar MJ J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of the binding of [3H]bremazocine in guinea-pig brain: evidence for multiplicity of the kappa-opioid receptors. Tiberi M; Magnan J Can J Physiol Pharmacol; 1989 Oct; 67(10):1336-44. PubMed ID: 2558788 [TBL] [Abstract][Full Text] [Related]
18. Effects of guanyl nucleotides and ions on kappa opioid binding. Mack KJ; Lee MF; Weyhenmeyer JA Brain Res Bull; 1985 Apr; 14(4):301-6. PubMed ID: 2988712 [TBL] [Abstract][Full Text] [Related]
19. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes. Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503 [TBL] [Abstract][Full Text] [Related]
20. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus. Meunier JC; Kouakou Y; Puget A; Moisand C Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]